Four-dimensional computed tomography (4D-CT) utilizes multiplanar images and perfusion characteristics to identify abnormal parathyroid glands. We assessed the role of 4D-CT in patients with inconclusive preoperative ultrasound and sestamibi localization studies.
Adult patients with primary hyperparathyroidism with negative or discordant standard imaging who underwent both localization with 4D-CT and operative intervention for curative intent were included. Patient characteristics, 4D-CT scan results compared with operative findings, and curative proportion were assessed.
Of the 60 patients, 4D-CT accurately lateralized 73% and localized 60% of abnormal glands found at operation. Single candidate lesions (46/60) were confirmed at operation in 70%. When multiple lesions were identified on 4D-CT (14/60), accuracy dropped to 29% (P = .03). The accuracy of 4D-CT was not different between primary and reoperative cases (P = .79). Of the 8 patients with multigland disease diagnosed perioperatively, 5 had multiple candidate lesions noted on 4D-CT. In 94% (48/51) of patients, a >50% drop in intraoperative parathormone (IOPTH) level was achieved after resection and 87% (48/55) had long-term cure with a median follow-up of 221 days.
4D-CT identifies the more than half of abnormal parathyroids missed by traditional imaging and should be considered in cases with negative or discordant sestamibi and ultrasound. Bilateral exploration is warranted when multiple candidate lesions are reported on 4D-CT. Multigland disease remains a challenging entity.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.N Engl J Med. 1980; 302: 189-193
- Hyperparathyroidism.Lancet. 2009; 374: 145-158
- The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism.Endocr Pract. 2005; 11: 49-54
- Primary hyperparathyroidism, cognition, and health-related quality of life.Ann Surg. 2005; 242: 642-650
- Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population.Clin Endocrinol (Oxf). 2004; 60: 335-342
- Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.BMJ. 2000; 321: 598-602
- The effect of parathyroidectomy on the recurrence of nephrolithiasis.Surgery. 1987; 102: 910-913
- A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.N Engl J Med. 1999; 341: 1249-1255
- Surgery in primary hyperparathyroidism: the patient without previous neck surgery.J Bone Miner Res. 2002; 17: N126-N132
- Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.Clin Endocrinol (Oxf). 1999; 50: 321-328
- Cardiovascular events before and after surgery for primary hyperparathyroidism.World J Surg. 2003; 27: 216-222
- Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.Surgery. 2006; 140: 932-940
- Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography.J Am Coll Surg. 2008; 206: 888-895
- Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.J Clin Endocrinol Metab. 2009; 94: 335-339
- National trends in parathyroid surgery from 1998 to 2008: a decade of change.J Am Coll Surg. 2009; 209: 332-343
- Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.Ann Surg. 2002; 235: 665-670
- Parathyroidectomy outcomes according to operative approach.Am J Surg. 2007; 193: 368-372
- Imaging for primary hyperparathyroidism–an evidence-based analysis.Langenbecks Arch Surg. 2009; 394: 765-784
- Can localization studies be used to direct focused parathyroid operations?.Surgery. 2001; 129: 720-729
- Primary hyperparathyroidism: can ultrasonography be the only preoperative diagnostic procedure?.Radiol Med. 2009; 114: 1159-1172
- Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.Arch Surg. 2005; 140: 472-478
- Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature.World J Surg. 2004; 28: 100-107
- Factors contributing to negative parathyroid localization: an analysis of 1000 patients.Surgery. 2008; 144: 74-79
- Surgeon performed ultrasound facilitates minimally invasive parathyroidectomy by the focused lateral mini-incision approach.World J Surg. 2008; 32: 766-771
- Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease.Am Surg. 2003; 69: 170-175
McCollough CH, Christner JA, Kofler JM. How effective is effective dose as a predictor of radiation risk? AJR Am J Roentgenol;194:890-6.
- Effective dose from radiopharmaceuticals.Eur J Nucl Med. 1992; 19: 933-938
Accepted: September 13, 2010
© 2010 Mosby, Inc. Published by Elsevier Inc. All rights reserved.